Crossmark

A comparative molecular analysis of DNA damage response, cell cycle progression, viability and apoptosis of malignant granulosa cells exposed to gemcitabine and cisplatin

Crossref DOI link: https://doi.org/10.1007/s11033-020-05426-2

Published Online: 2020-04-10

Published Print: 2020-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bildik, Gamze

Esmaeilian, Yashar

Vatansever, Dogan

Bilir, Esra

Taskiran, Cagatay

Oktem, Ozgur
Funding

Funding for this research was provided by:

Koc University Research Center for Translational Medicine (-)
License Information

Text and Data Mining valid from 2020-04-10

Version of Record valid from 2020-04-10
More Information

Article History

Received: 16 February 2020

Accepted: 3 April 2020

First Online: 10 April 2020

Compliance with ethical standards

:

: The authors declare that there are no conflicts of interest.

: Research conducted in this study do not involve human participants or animals, therefore it is exempt from informed consent statement.

Document is current

Any future updates will be listed below